| | 188627-80-7 Basic information More.. |
| Product Name: | Eptifibatide | | Synonyms: | MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;MPA-HAR-GLY-ASP-TRP-PRO-CYS-NH2(DISULFIDE BRIDGE, MPA1-CYS6);Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2 | | CAS: | 188627-80-7 | | MF: | C35H49N11O9S2 | | MW: | 831.96 | | EINECS: | 641-366-7 | | Mol File: | 188627-80-7.mol |  |
Use
Eptifibatide (Integrilin) is a syntheticcyclic heptapeptide that acts as a GPIIb/IIIa receptor antagonist,thus causing inhibition of platelet aggregation. Itsstructure is based on the natural product barbourin, a peptideisolated from the venom of a pygmy rattlesnake (Sistrurusmilarud barbouri). As part of the structure, there is a sequenceRGD that can bind to the RGD receptor found onplatelets and block its ability to bind with fibrinogen. Thisagent is used in the treatment of unstable angina and for angioplasticcoronary interventions.
- Eptifibatide
-
- US $30.00 / box
- 2024-04-30
- CAS:188627-80-7
- Min. Order: 1box
- Purity: 98%
- Supply Ability: 5000box
- Eptifibatide
-
- US $0.00 / Kg/Bag
- 2024-04-22
- CAS:188627-80-7
- Min. Order: 2Kg/Bag
- Purity: 99% min / FDA / DMF
- Supply Ability: 20 tons
- Eptifibatide
-
- US $26.00 / box
- 2024-04-17
- CAS:188627-80-7
- Min. Order: 1box
- Purity: 99%
- Supply Ability: 20000box
|
|
188627-80-7
Recommend Suppliers |
|